RaQualia selects Miner3D for its visual data analysis platform
18 September 2008Tweet
RaQualia Pharma will use Miner3D as its main R&D data analytics platform.
RaQualia, a pharmaceutical research and development company, is a spin-off of drug maker giant Pfizer. The company focuses on pain and gastrointestinal therapeutic areas and manages six drug discovery programs.
Miner3D helps RaQualia’s scientists and researchers to better understand vast amounts of scientific data, improve leads identification and speed up research and development processes.